Erika Söderberg Johnson
Chief Financial Officer of Biotage
Erika Söderberg Johnson is Chief Financial Officer of Biotage since January 2012. Mrs. Söderberg Johnson has previously been Chief Financial Officer at Karo Bio (2007-2011), Affibody (2005-2007) and Global Genomics (2002-2005). Prior to this, Mrs. Söderberg Johnson worked ten years in Investment Banking and Corporate Finance at SEB Enskilda. She is a board member of publicly listed companies Saab AB (since 2017), Qliro Group AB (since 2017). Mrs. Söderberg Johnson was born in 1970, and has a M. Sc. BA from the Stockholm School of Economics.
Helena Ströberg, M.Sc., Business Development. “I am passionate about creating opportunities so that players in the life science industry become more successful, thus contributing to growth in our region as well as in Sweden.”